These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7235668)

  • 21. [Pharmacokinetics of tobramycetin and gentamycin and the mechanism of their elimination by the kidneys].
    Filippos'iants ST; Kunrat IA; Gol'dberg LE
    Antibiotiki; 1980 Aug; 25(8):579-84. PubMed ID: 7406469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels and urinary excretion of parent antibiotics and desacetyl forms after parenteral administration of cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):628-33. PubMed ID: 1160152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition kinetics and bioavailability of piperacillin and cephapirin in mares.
    el-Komy AA
    Dtsch Tierarztl Wochenschr; 1995 Jun; 102(6):244-8. PubMed ID: 8582260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial agents in rats. I. Serum levels of parenteral cephalosporins.
    Marre R; Freiesleben H
    Arzneimittelforschung; 1979; 29(6):932-4. PubMed ID: 582786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum half-lives and elimination rates of a new semi-synthetic cephalosporin, cephacetrile, in nephrectomized patients and in patients with impaired or normal renal function.
    Reutter F; Maurice NP
    Arzneimittelforschung; 1974 Sep; 24(9b):1466-8. PubMed ID: 4479804
    [No Abstract]   [Full Text] [Related]  

  • 26. Ceftezole, a new cephalosporin C derivative II. Distribution and excretion in parenteral administration.
    Harada Y; Matsubara S; Kakimoto M; Noto T; Nehashi T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1071-82. PubMed ID: 994326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and clinical use of cephalosporin antibiotics.
    Nightingale CH; Greene DS; Quintiliani R
    J Pharm Sci; 1975 Dec; 64(12):1899-926. PubMed ID: 1107514
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics of cefapirin in patients with normal and impaired renal functions.
    Bergan T; Orjavik O; Brodwall EK
    Arzneimittelforschung; 1981; 31(10):1773-6. PubMed ID: 7198453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.
    Barza M; Melethil S; Berger S; Ernst EC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):421-5. PubMed ID: 984783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetics and metabolism of cephapirin in laboratory animals and humans.
    Cabana BE; van Harken DR; Hottendorf GH
    Antimicrob Agents Chemother; 1976 Aug; 10(2):307-17. PubMed ID: 984774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative review of the pharmacokinetics of boric acid in rodents and humans.
    Murray FJ
    Biol Trace Elem Res; 1998; 66(1-3):331-41. PubMed ID: 10050928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney transport of cefapirin in normal and impaired renal function.
    Brodwall EK; Orjavik O; Bergan T
    Arzneimittelforschung; 1981; 31(12):2157-9. PubMed ID: 7199318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: renal clearance in rats and rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Aug; 34(8):1055-63. PubMed ID: 6274837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative serum levels and protective activity of parenterally administered cephalosporins in experimental animals.
    Fare LR; Actor P; Sachs C; Phillips L; Joloza M; Pauls JF; Weisbach JA
    Antimicrob Agents Chemother; 1974 Aug; 6(2):150-5. PubMed ID: 15828185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pharmacokinetic comparison of cefadroxil and cephalexin after administration of 250, 500 and 1000 mg solution doses.
    Barbhaiya RH
    Biopharm Drug Dispos; 1996 May; 17(4):319-30. PubMed ID: 8743403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.
    Yamazaki I; Shirakawa Y; Fugono T
    J Antibiot (Tokyo); 1981 Nov; 34(11):1476-85. PubMed ID: 6274834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newly identified degradation products of ceftiofur and cephapirin impact the analytical approach for quantitative analysis of kidney.
    Berendsen BJ; Essers ML; Mulder PP; van Bruchem GD; Lommen A; van Overbeek WM; Stolker LA
    J Chromatogr A; 2009 Nov; 1216(46):8177-86. PubMed ID: 19406407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacokinetic studies of cephapirin and cephalothin following intravenous and intramuscular administration.
    Lane AZ; Chudzik GM; Siskin SB
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):117-27. PubMed ID: 401706
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacokinetics of cephapirin sodium during intravenous infusion].
    Imoto T
    Jpn J Antibiot; 1983 Aug; 36(8):2120-8. PubMed ID: 6655830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic fate of cephacetrile after parenteral administration in rats and rabbits.
    Nakai Y; Kanai Y; Fugono T; Tanayama S
    J Antibiot (Tokyo); 1976 Jan; 29(1):81-90. PubMed ID: 931795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.